Literature DB >> 24989974

Solution NMR structures of immunoglobulin-like domains 7 and 12 from obscurin-like protein 1 contribute to the structural coverage of the Human Cancer Protein Interaction Network.

Surya V S R K Pulavarti1, Yuanpeng J Huang, Kari Pederson, Thomas B Acton, Rong Xiao, John K Everett, James H Prestegard, Gaetano T Montelione, Thomas Szyperski.   

Abstract

High-quality solution NMR structures of immunoglobulin-like domains 7 and 12 from human obscurin-like protein 1 were solved. The two domains share 30% sequence identity and their structures are, as expected, rather similar. The new structures contribute to structural coverage of human cancer associated proteins. Mutations of Arg 812 in domain 7 cause the rare 3-M syndrome, and this site is located in a surface area predicted to be involved in protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24989974      PMCID: PMC4945113          DOI: 10.1007/s10969-014-9185-y

Source DB:  PubMed          Journal:  J Struct Funct Genomics        ISSN: 1345-711X


  35 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA.

Authors:  Torsten Herrmann; Peter Güntert; Kurt Wüthrich
Journal:  J Mol Biol       Date:  2002-05-24       Impact factor: 5.469

3.  Assignment validation software suite for the evaluation and presentation of protein resonance assignment data.

Authors:  Hunter N B Moseley; Gurmukh Sahota; Gaetano T Montelione
Journal:  J Biomol NMR       Date:  2004-04       Impact factor: 2.835

4.  Automated analysis of protein NMR assignments using methods from artificial intelligence.

Authors:  D E Zimmerman; C A Kulikowski; Y Huang; W Feng; M Tashiro; S Shimotakahara; C Chien; R Powers; G T Montelione
Journal:  J Mol Biol       Date:  1997-06-20       Impact factor: 5.469

5.  Molecular basis of the head-to-tail assembly of giant muscle proteins obscurin-like 1 and titin.

Authors:  Florian Sauer; Juha Vahokoski; Young-Hwa Song; Matthias Wilmanns
Journal:  EMBO Rep       Date:  2010-05-21       Impact factor: 8.807

6.  The high-throughput protein sample production platform of the Northeast Structural Genomics Consortium.

Authors:  Rong Xiao; Stephen Anderson; James Aramini; Rachel Belote; William A Buchwald; Colleen Ciccosanti; Ken Conover; John K Everett; Keith Hamilton; Yuanpeng Janet Huang; Haleema Janjua; Mei Jiang; Gregory J Kornhaber; Dong Yup Lee; Jessica Y Locke; Li-Chung Ma; Melissa Maglaqui; Lei Mao; Saheli Mitra; Dayaban Patel; Paolo Rossi; Seema Sahdev; Seema Sharma; Ritu Shastry; G V T Swapna; Saichu N Tong; Dongyan Wang; Huang Wang; Li Zhao; Gaetano T Montelione; Thomas B Acton
Journal:  J Struct Biol       Date:  2010-08-03       Impact factor: 2.867

7.  Protein backbone angle restraints from searching a database for chemical shift and sequence homology.

Authors:  G Cornilescu; F Delaglio; A Bax
Journal:  J Biomol NMR       Date:  1999-03       Impact factor: 2.835

8.  Torsion angle dynamics for NMR structure calculation with the new program DYANA.

Authors:  P Güntert; C Mumenthaler; K Wüthrich
Journal:  J Mol Biol       Date:  1997-10-17       Impact factor: 5.469

9.  Targeting the human cancer pathway protein interaction network by structural genomics.

Authors:  Yuanpeng Janet Huang; Dehua Hang; Long Jason Lu; Liang Tong; Mark B Gerstein; Gaetano T Montelione
Journal:  Mol Cell Proteomics       Date:  2008-05-18       Impact factor: 5.911

10.  Stereospecific nuclear magnetic resonance assignments of the methyl groups of valine and leucine in the DNA-binding domain of the 434 repressor by biosynthetically directed fractional 13C labeling.

Authors:  D Neri; T Szyperski; G Otting; H Senn; K Wüthrich
Journal:  Biochemistry       Date:  1989-09-19       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.